Charles Elliott Sigal

Insider Reports History

Location
Princeton, NJ
Signature
/s/ Vanina de Verneuil, Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Charles Elliott Sigal:

Company Role Class Num Shares Value Price $ Report Date Ownership
ALNYLAM PHARMACEUTICALS, INC. Director Common Stock 2,000 $465,900 $232.95 08 May 2025 by Trust
Vir Biotechnology, Inc. Director Common Stock 31,806 $195,606 $6.15 30 May 2025 Direct
ALNYLAM PHARMACEUTICALS, INC. Director Common Stock 775 $180,536 $232.95 08 May 2025 Direct
Vir Biotechnology, Inc. Director Common Stock 10,000 $61,500 $6.15 30 May 2025 By Sigal Family Investments, LLC
Vir Biotechnology, Inc. Director Stock Option (Right to Buy) 16,000 $24,480 $1.53 30 May 2025 Direct
Adaptimmune Therapeutics PLC Director Option to purchase Ordinary Shares 933,317 03 Jul 2023 Direct
ALNYLAM PHARMACEUTICALS, INC. Director Stock Option (right to buy) 1,558 08 May 2025 Direct
Surface Oncology, Inc. Director Common Stock 0 $0.9400 08 Sep 2023 Indirect
Surface Oncology, Inc. Director Stock Option (Right to Buy) 0 08 Sep 2023 Direct

Insider Reports Filed by Charles Elliott Sigal

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VIR Vir Biotechnology, Inc. 30 May 2025 2 $0 4 Director 02 Jun 2025, 19:31
ALNY ALNYLAM PHARMACEUTICALS, INC. 08 May 2025 2 $0 4 Director 12 May 2025, 16:04
VIR Vir Biotechnology, Inc. 30 May 2024 2 $0 4 Director 03 Jun 2024, 12:18
ALNY ALNYLAM PHARMACEUTICALS, INC. 16 May 2024 1 $0 4 Director 20 May 2024, 16:08
/report/000120919123048762-sigal-charles-elliott-2023-09-08 Surface Oncology, Inc. 08 Sep 2023 2 $0 4 Director 08 Sep 2023, 16:00
ADAP Adaptimmune Therapeutics PLC 03 Jul 2023 1 $0 4 Director 03 Jul 2023, 17:02
VIR Vir Biotechnology, Inc. 22 May 2023 2 $0 4 Director 24 May 2023, 14:33
ALNY ALNYLAM PHARMACEUTICALS, INC. 18 May 2023 1 $0 4 Director 19 May 2023, 16:06
VIR Vir Biotechnology, Inc. 01 Mar 2023 1 +$56,816 4 Director 02 Mar 2023, 15:27
VIR Vir Biotechnology, Inc. 05 Jan 2023 1 +$62,396 4 Director 09 Jan 2023, 10:51
VIR Vir Biotechnology, Inc. 03 Jan 2023 2 +$127,129 4 Director 05 Jan 2023, 16:00
ALNY ALNYLAM PHARMACEUTICALS, INC. 22 Aug 2022 1 $0 4 Director 24 Aug 2022, 16:08
ALNY ALNYLAM PHARMACEUTICALS, INC. 22 Aug 2022 0 $0 3 Director 24 Aug 2022, 16:07
ADAP Adaptimmune Therapeutics PLC 01 Jul 2022 1 $0 4 Director 01 Jul 2022, 17:01
/report/000120919122036151-sigal-charles-elliott-2022-06-08 Surface Oncology, Inc. 08 Jun 2022 1 $0 4 Director 10 Jun 2022, 20:00
VIR Vir Biotechnology, Inc. 23 May 2022 2 $0 4 Director 25 May 2022, 18:09
ADAP Adaptimmune Therapeutics PLC 01 Jul 2021 1 $0 4 Director 02 Jul 2021, 17:01
/report/000120919121039464-sigal-charles-elliott-2021-06-08 Surface Oncology, Inc. 08 Jun 2021 1 $0 4 Director 10 Jun 2021, 16:30
VIR Vir Biotechnology, Inc. 21 May 2021 2 $0 4 Director 25 May 2021, 16:48